THE WORLDWIDE CLINICAL DIAGNOSTICS MARKET

331 Pages | 95 Exhibits | 2012 Analysis | Forecasts Through 2017 Product Family: Market Reports




OVERVIEW:
Major Topics

•  Trends in the global Clinical Diagnostics market and 2011-2017 market analysis by segment
•  Factors driving growth in clinical diagnostic testing
•  Assessment of regulatory environment by country/region
•  Clinical chemistry market analysis, including chemistry, critical care testing, whole blood glucose monitoring and urinalysis
•  Immunodiagnostics market analysis including general-purpose and specialty immunoassays and blood screening tests
•  Hematology, flow cytometry and coagulation testing market analysis
•  Microbiology market analysis
•  Molecular diagnostics market analysis including infectious disease testing, cancer and genetic testing, companion diagnostics, and blood typing/screening
•  Analysis of point-of-care testing, home and self-testing, and cancer diagnostics markets
•  Market analysis by country/region including analysis by product segment for the U.S., Japan, Germany, France, Italy, the UK, Spain, Rest of Europe, and Rest of World plus market assessment for China and India
•  Current and forecast market size (2011-2017), pricing trends, and analysis of competitive factors
•  Key business transactions, competitor strategies, strategies for success in Clinical Diagnostics
•  In-depth profiles of 25 companies

TABLE OF CONTENTS:
EXECUTIVE SUMMARY

Exhibit ES-1: Worldwide Clinical Diagnostics Market by Segment
Exhibit ES-2: U.S. Diagnostic Testing Service Provider Market, 2011
Exhibit ES-3: Worldwide Market by Test Type
Exhibit ES-4: Clinical Diagnostics Market by Country/Region
Exhibit ES-5: Market Segment Growth Rate Comparison
Exhibit ES-6: Worldwide Sales and Market Share for Leading Suppliers
Exhibit ES-7: Sales by Segment for Leading Suppliers, 2011

1. INTRODUCTION

1.1 Technology Trends in Clinical Diagnostics
	1.1.1 Molecular Diagnostics
	1.1.2 Point-of-Care Testing
	1.1.3 Informatics
	1.1.4 Microarrays, Lab-on-a-Chip Devices, and Next-Generation Sequencing
	1.1.5 Laboratory Automation
1.2 Drivers and Limiters of the Clinical Diagnostics Market
1.3 Major Trends in the Clinical Diagnostics Market
	1.3.1 Targeted Therapeutics and Diagnostics
	1.3.2 Industry Globalization
	1.3.3 Expansion of IVD Suppliers
1.4 Segments of Opportunity and Risk in the Clinical Diagnostics Market

Exhibit 1.1: 2011 Global Clinical Diagnostic and Diagnostic Imaging Market
Exhibit 1.2: Key Factors Driving Adoption of POC Testing
Exhibit 1.3: Expansion of Clinical Lab Automation in the U.S.
Exhibit 1.4: High and low-growth product segments of the clinical diagnostics market

2. INDUSTRY OVERVIEW

2.1 Clinical Chemistry Segment
	2.1.1 Trends in General Chemistry Testing
	2.1.2 Critical Care Testing
	2.1.3 Urinalysis Testing
	2.1.4 Whole Blood Glucose Testing
2.2 Immunodiagnostics Market and Subsegments
2.3 Microbiology Segment
2.4 Hematology and Cell Imaging Segments
2.5 Molecular Diagnostics Segment
2.6 Other Clinical Diagnostics Market Segments
	2.6.1 Coagulation Testing
	2.6.2 Cytology and Histology
	2.6.3 Other Subsegments
	
Exhibit 2.1: Highest Volume Laboratory Tests Performed in the U.S. Medicare Population
Exhibit 2.2: Chemistry Testing Products
Exhibit 2.3: Critical Care Testing Products
Exhibit 2.4: Diabetes Prevalence Trends
Exhibit 2.5: Automated and Semi-Automated Immunoassay Analyzers
Exhibit 2.6: Microbiology Test Systems
Exhibit 2.7: Hematology/cell analysis products
Exhibit 2.8 Molecular diagnostics products
Exhibit 2.9 Coagulation testing products	
	
3. REGULATORY ENVIRONMENT

3.1 The IVD Medical Devices Directive
3.2 U.S. Regulatory Requirements
3.3 Regulatory Requirements in Japan
3.4 Regulatory Requirements in Other Regions
	3.4.1 China
	3.4.2 India
	3.4.3 Other Asian Countries
	3.4.4 Africa
	3.4.5 Canada
	3.4.6 Australia
	3.4.7 Latin America
3.5 Status of Harmonization of Regulations Between Countries

4. TECHNOLOGY DEVELOPMENTS

4.1 POC Testing Technology
	4.1.1 Impact of Device Miniaturization
	4.1.2 Less Invasive and Noninvasive Testing Technologies
	4.1.3 Wireless Technologies and POC Testing
4.2 Molecular Diagnostics Technologies
	4.2.1 Microarrays in Molecular Diagnostics
	4.2.2 Automation of Molecular Testing
	4.2.3 Advances in Genotyping, Haplotyping, and Sequencing Technology
4.3 Companion Diagnostics and Pharmacogenomics
4.4 Advances in Informatics Technology
4.5 Proteomics Technology

Exhibit 4.1: Noninvasive, Minimally Invasive and Continuous Glucose Monitoring Technologies
Exhibit 4.2: Microarrays for Molecular Diagnostics
Exhibit 4.3: Next-Generation Sequencing Technologies

5. MARKET OVERVIEW

5.1 Overview of Sales by Product Segment
5.2 Overview of Sales by Country
5.3 Analysis of Market by Application Segment
5.4 Role of Clinical Diagnostics in Healthcare
5.5 Sites for Clinical Diagnostic Testing
5.6 Major Trends in the Clinical Diagnostics Market
5.7 Characteristics of the Clinical Diagnostics Market by Region
	5.7.1 U.S. Market
	5.7.2 Japanese Market
	5.7.3 German Market
	5.7.4 Italian Market
	5.7.5 French Market
	5.7.6 U.K. Market
	5.7.7 Spanish Market
	5.7.8 Chinese Market
	5.7.9 Indian Market
5.8 Future Impact of Molecular Diagnostics, Companion Diagnostics/Pharmacogenomics and Proteomics
5.9 Segments of the Clinical Diagnostics Products Market

Exhibit 5.1: Global Clinical Diagnostic Products Market by Product Segment, 2011-2017
Exhibit 5.2: Distribution of Global Clinical Diagnostic Products Market by Product Segment, 2011 and 2017
Exhibit 5.3: Global Clinical Diagnostic Products Market by Country/Region, 2011-2017
Exhibit 5.4: Distribution of Global Clinical Diagnostic Products Market by Country/Region, 2011 and 2017
Exhibit 5.5: Global Clinical Diagnostic Products Market Size and Growth by Application Segment, 2011-2017
Exhibit 5.6: Distribution of global clinical diagnostic products market by application segment, 2011 and 2017
Exhibit 5.7: Segmentation of Health Care Costs in the U.S.
Exhibit 5.8: Number of CLIA-registered clinical laboratories by type, 2001 and 2011
Exhibit 5.9: Worldwide Clinical Diagnostic Products Market by Region
Exhibit 5.10: Size of the worldwide clinical diagnostic products market by market segment
Exhibit 5.11: Size of the worldwide clinical chemistry market segments
Exhibit 5.12: Size of the worldwide immunodiagnostics market segments
Exhibit 5.13: Microbiology products market
Exhibit 5.14: Hematology/flow cytometry and coagulation testing products market
Exhibit 5.15: Worldwide molecular diagnostics products market
Exhibit 5.16: Leading Suppliers in the Global Clinical Diagnostics Market, 2011
Exhibit 5.17: Niche and Emerging Suppliers in the Global Clinical Diagnostics Market, 2011

6. PRODUCT SEGMENTS

6.1 Clinical Chemistry Products
	6.1.1 Integrated testing platforms
	6.1.2 High-Throughput Chemistry Systems
	6.1.3 Mid-Range Chemistry Systems
	6.1.4 Low-Throughput/Alternate Site Chemistry Systems
	6.1.5 Urinalysis Products
	6.1.6 Critical Care Testing Products
	6.1.7 Market Segmentation for Clinical Chemistry Products
6.2 Immunodiagnostic Products
	6.2.1 General Purpose Immunodiagnostic Systems
	6.2.2 Specialty Immunodiagnostic Systems
	6.2.3 Immunoassay-Based Blood Screening Systems
	6.2.4 Market Segmentation for Immunodiagnostic Products
6.3 Hematology/Cellular Analysis and Coagulation Testing Products
	6.3.1 Conventional Hematology and Integrated Hematology Systems
	6.3.2 Dedicated Flow Cytometry Systems
	6.3.3 Flow Cytometry Reagents
	6.3.4 Coagulation Testing Products
	6.3.5 Market Segmentation for Hematology/Flow Cytometry and Coagulation Testing Products
6.4 Cancer Diagnostic Products
6.5 Molecular Diagnostic Products
	6.5.1 Infectious Disease Testing Products
	6.5.2 Blood Screening (NAT) Products
	6.5.3 Genetic Testing Products
	6.5.4 Companion Diagnostics/Pharmacogenomic Testing Products
	6.5.5 Viral Load/Viral Genotyping Products
	6.5.6 Molecular Diagnostics Market Segmentation
6.6 POC Testing Products
	6.6.1 Bedside Critical Care Testing Products
	6.6.2 Alternate Site Coagulation/Platelet Function Monitoring Products
	6.6.3 Drugs of Abuse Screening Kits
	6.6.4 Professional-Use Whole Blood Chemistry Testing Systems
	6.6.5 POC Cardiac Marker Testing Products
	6.6.6 Rapid Infectious Disease Test Kits
	6.6.7 Other POC Products
	6.6.8 POC Testing Market Segmentation
6.7 Home and Self-Testing Products
	6.7.1 Whole Blood and Minimally Invasive Glucose Testing Products
	6.7.2 Home Tests for Monitoring of Glycated Hemoglobin
	6.7.3 Coagulation Self-Testing Products
	6.7.4 Home Pregnancy and Fertility Products
	6.7.5 Home Cholesterol Testing Products
	6.7.6 Home Drugs of Abuse Test Kits
	6.7.7 Home and Self-Testing Market Segmentation
6.8 Other Clinical Diagnostic Products

Exhibit 6.1: Clinical chemistry products
Exhibit 6.2: Clinical Chemistry Market Segmentation by Product Type, 2011
Exhibit 6.3: General purpose immunodiagnostic products
Exhibit 6.4: Immunodiagnostics Market by Product Segment, 2011
Exhibit 6.5: Hematology and coagulation products
Exhibit 6.6: Hematology/Flow Cytometry/Coagulation Testing Market by Product Segment, 2011
Exhibit 6.7: Cancer diagnostic products
Exhibit 6.8: Serum tumor markers and their clinical applications
Exhibit 6.9: Cancer Diagnostic Products Market by Product Segment, 2011
Exhibit 6.10: Molecular diagnostic products
Exhibit 6.11: Molecular Diagnostics Testing Products Market by Product Segment, 2011
Exhibit 6.12: POC testing products
Exhibit 6.13: Point-of-Care (POC) Testing Products Market by Product Segment, 2011
Exhibit 6.14: Home and self-testing products
Exhibit 6.15: Home and Self-Testing Products Market by Product Segment, 2011
Exhibit 6.16: Other clinical diagnostic products

7. MARKET ANALYSIS BY END USER

7.1 Traditional Laboratory-Based Testing
7.2 Testing in Other Sites
7.3 Testing in the U.S.
7.4 Testing in Europe
7.5 Testing in Japan
7.6 Testing in China
7.7 Testing in India
7.8 Testing in the Rest of World Region
7.9 Future Trends

Exhibit 7.1: Changes to the Clinical Laboratory Fee Schedule in the U.S., 2000-2012
Exhibit 7.2: Number of Clinical Laboratories in Selected Countries
Exhibit 7.3: Segmentation of Laboratory-Based Testing in the U.S., 2011
Exhibit 7.4: Trends in the Site of Laboratory-Based Testing in the U.S., 2002-2012
Exhibit 7.5: Estimated distribution of hospital and clinic laboratories in major European Countries, 2012
Exhibit 7.6: Trends in Health Care Expenditures as a Percentage of GDP, 2000-2010
Exhibit 7.7: Number of Medical Institutions in China

8. MARKET ANALYSIS BY COUNTRY

8.1 U.S. Market
	8.1.1 Clinical Chemistry Market
	8.1.2 Critical Care Testing Market
	8.1.3 Urinalysis Market
	8.1.4 Blood Glucose Market
	8.1.5 Immunodiagnostics Market
	8.1.6 Hematology Market
	8.1.7 Microbiology Market
	8.1.8 Coagulation/Platelet Function Testing Market
	8.1.9 Molecular Diagnostics Market
	8.1.10 Other Product Market Segments
8.2 Japanese Market
	8.2.1 Clinical Chemistry Market
	8.2.2 Critical Care Testing Market
	8.2.3 Urinalysis Market
	8.2.4 Blood Glucose Market
	8.2.5 Immunodiagnostics Market
	8.2.6 Hematology Market
	8.2.7 Microbiology Market
	8.2.8 Coagulation Testing Market
	8.2.9 Molecular Diagnostics Market
	8.2.10 Other Product Market Segments
8.3 German Market
	8.3.1 Clinical Chemistry Market
	8.3.2 Critical Care Testing Market
	8.3.3 Urinalysis Market
	8.3.4 Blood Glucose Market
	8.3.5 Immunodiagnostics Market
	8.3.6 Hematology Market
	8.3.7 Microbiology Market
	8.3.8 Coagulation Testing Market
	8.3.9 Molecular Diagnostics Market
	8.3.10 Other Product Market Segments
8.4 French Market
	8.4.1 Clinical Chemistry Market
	8.4.2 Critical Care Testing Market
	8.4.3 Urinalysis Market
	8.4.4 Blood Glucose Market
	8.4.5 Immunodiagnostics Market
	8.4.6 Hematology Market
	8.4.7 Microbiology Market
	8.4.8 Coagulation Testing Market
	8.4.9 Molecular Diagnostics Market
	8.4.10 Other Product Market Segments
8.5 Italian Market
	8.5.1 Clinical Chemistry Market
	8.5.2 Critical Care Testing Market
	8.5.3 Urinalysis Market
	8.5.4 Blood Glucose Market
	8.5.5 Immunodiagnostics Market
	8.5.6 Hematology Market
	8.5.7 Microbiology Market
	8.5.8 Coagulation Testing Market
	8.5.9 Molecular Diagnostics Market
	8.5.10 Other Product Market Segments
8.6 U.K. Market
8.7 Rest of Europe and Rest of World Markets
	8.7.1 Rest of Europe
	8.7.2 China
	8.7.3 India
	8.7.4 Rest of World
8.8 Country Markets by Testing Discipline

Exhibit 8.1: Breakdown of the global clinical diagnostics market by country/region, 2011
Exhibit 8.2: The U.S. clinical diagnostics market by segment 
Exhibit 8.3: The Japan clinical diagnostics market by segment 
Exhibit 8.4: The German clinical diagnostics market by segment 
Exhibit 8.5: The French clinical diagnostics market by segment 
Exhibit 8.6: The Italian clinical diagnostics market by segment 
Exhibit 8.7: The U.K. clinical diagnostics market by segment 
Exhibit 8.8: The Rest of Europe clinical diagnostics market by segment 
Exhibit 8.9: The Rest of World clinical diagnostics market by segment 
Exhibit 8.10: Country/regional markets, clinical chemistry 
Exhibit 8.11: Country/regional markets, critical care testing 
Exhibit 8.12: Country/regional markets, urinalysis 
Exhibit 8.13: Country/regional markets, whole blood glucose 
Exhibit 8.14: Country/regional markets, immunodiagnostics 
Exhibit 8.15: Country/regional markets, hematology/flow cytometry 
Exhibit 8.16: Country/regional markets, microbiology 
Exhibit 8.17: Country/regional markets, molecular diagnostics 
Exhibit 8.18: Country/regional markets, coagulation 
Exhibit 8.19: Country/regional markets, other 
Exhibit 8.20: Percentage share per country/region of the global clinical chemistry market, 2011
Exhibit 8.21: Percentage share per country/region of the global critical care testing market, 2011
Exhibit 8.22: Percentage share per country/region of the global urinalysis market, 2011
Exhibit 8.23: Percentage share per country/region of the global whole blood glucose testing products market, 2011
Exhibit 8.24: Percentage share per country/region of the global immunodiagnostics products market, 2011
Exhibit 8.25: Percentage share per country/region of the global hematology/flow cytometry products market, 2011
Exhibit 8.26: Percentage share per country/region of the global microbiology products market, 2011
Exhibit 8.27: Percentage share per country/region of the global molecular diagnostics market, 2011
Exhibit 8.28: Percentage share per country/region of the global coagulation testing products market, 2011
Exhibit 8.29: Percentage share per country/region of the global other clinical diagnostics products market, 2011	

9. COMPANY ANALYSIS

9.1 Overview of Clinical Diagnostic Product Suppliers
	9.1.1 Industry Leaders
	9.1.2 Niche Suppliers and Emerging Companies
9.2 Mergers and Acquisitions in the Clinical Diagnostics Industry
9.3 Perspectives and Strategies of Key Suppliers
	9.3.1 Siemens Diagnostics
	9.3.2 Abbott Diagnostics
	9.3.3 Roche Diagnostics
	
Exhibit 9.1: Worldwide sales by market segment for leading suppliers in the clinical diagnostics market, 2011
Exhibit 9.2: Market segment focus, sales and growth of emerging and niche suppliers in the clinical diagnostics market, 2011	
		
10. COMPANY PROFILES

10.1 Abbott
10.2 Alere
	10.2.1 Biosite
	10.2.2 Hemosense
	10.2.3 Cholestech
10.3 A. Menarini Diagnostics
10.4 Arkray
10.5 Bayer Diabetes Care
10.6 BD
10.7 bioMerieux
10.8 Bio-Rad Laboratories
10.9 Cepheid
10.10 Danaher
	10.10.1 Beckman Coulter
	10.10.2 Radiometer
10.11 DiaSorin
10.12 Digene/Qiagen
10.13 Fujirebio
10.14 Grifols Diagnostics
10.15 Hologic
	10.15.1 Cytyc
	10.15.2 Gen-Probe
10.16 Instrumentation Laboratory
10.17 IRIS International
10.18 Meridian
10.19 NOVA Biomedical
10.20 Ortho Clinical Diagnostics/LifeScan
10.21 Roche Diagnostics
10.22 Siemens Diagnostics
10.23 Stago
10.24 Sysmex
10.25 Tosoh

11. STRATEGIES FOR SUCCESS

11.1 Consolidation and Information Technology
11.2 Targeting of High Growth/High-Value Segments
11.3 Technology Strategies
11.4 Marketing and Distribution Strategies for the Clinical Diagnostics Market

Exhibit 11.1: Market segment participation of the top clinical diagnostics companies, 2011

COMPANY DIRECTORY



COMPANIES COVERED:

  1. A. Menarini Diagnostics
  2. Abaxis Inc.
  3. Abbott Laboratories Inc.
  4. Accelr8 Technology Corp.
  5. Accu-Stat Diagnostics
  6. Accuri Cytometers Inc.
  7. Accutech LLC
  8. ACON Laboratories
  9. Advantage Diagnostics
  10. Affymetrix
  11. Aggredyne, Inc.
  12. AiMedics Pty Ltd.
  13. Alacris Theranostics GmbH
  14. Alfa Scientific Designs
  15. Alfa Wassermann S.p.A
  16. Allscripts-Mysis
  17. Alternecare Health Products
  18. American Biomedica Corporation
  19. American Labor/Lab ACM
  20. AmerisourceBergen Corporation
  21. Amgen
  22. Amic AB
  23. Applied Biosystems (Life Technologies)
  24. Araclon Biotech S.L.
  25. Argene SA
  26. Aria Diagnostics
  27. ARK Diagnostics, Inc.
  28. Arlington Scientific
  29. ARUP Laboratories
  30. AstraZeneca PLC
  31. Assel S.r.l.
  32. Australian Diagnostic Imaging Association
  33. AutoGenomics, Inc.
  34. Awareness Technology
  35. Axis-Shield plc
  36. Bayer AG
  37. Bayer Corporation
  38. Beckman Coulter
  39. Becton Dickinson
  40. BG Medicine, Inc.
  41. Biocartis
  42. Biacore (GE Healthcare)
  43. Binax (Inverness Medical)
  44. The Binding Site Group Ltd
  45. Biocytex
  46. Bio/Data
  47. BioGenex Laboratories, Inc.
  48. BioImagene
  49. BioMerieux
  50. Bio-Rad Laboratories
  51. Biosafe Laboratories
  52. Biosite Diagnostics
  53. Biotage
  54. Biotex
  55. Bioview Ltd.
  56. BioView Ltd.
  57. Blue Ocean Biomedical LLC
  58. Bodytel
  59. Boule Diagnostics
  60. B•R•A•H•M•S Aktiengesellschaft
  61. Brahms Diagnostica USA
  62. Cambridge Consultants
  63. Cardinal Health
  64. Cardiocom
  65. CardioDx
  66. Carl Zeiss AG
  67. Celera Diagnostics
  68. CellaVision Inc.
  69. Cepheid Inc.
  70. Cerner Corporation
  71. Cernostics Pathology, Inc.
  72. Ciphergen Biosystems
  73. Chempaq
  74. Chiron (unit of Novartis)
  75. Cholestech
  76. Church & Dwight
  77. CH Werfen/Werfen Life Group
  78. Clinical Data
  79. CLB, Sanquin Blood Supply Foundation
  80. ClearBlue
  81. Clearbridge BioMedics
  82. ClonTech Laboratories, Inc.
  83. CombiMatrix
  84. COWIN GLOBAL GERMANY GMBH
  85. Crony Instruments
  86. CVS Caremark
  87. Dako Denmark A/S
  88. Da An Gene Co., Ltd. of Sun Yat-Sen Uni
  89. Danaher
  90. Definiens
  91. Dexcom
  92. DiagnoSwiss
  93. Diagnostica Stago
  94. Diagnostic Products Corporation
  95. Diamedix Corporation
  96. DiaSorin
  97. Diesse Diagnostica
  98. Digene (see Qiagen)
  99. Digital Genomics, Inc.
  100. Dirui Industrial Co. Ltd.
  101. DNA Direct
  102. DNA Electronics Ltd
  103. DxS Ltd ((Now Qiagen)
  104. Echo Therapeutics
  105. Edwards Medical Supply
  106. eHIT Ltd
  107. EKF Diagnostics
  108. Eli Lilly and Company
  109. Epocal
  110. EraGen Biosciences, Inc.
  111. ESA Inc. (Dionex)
  112. ExonHit Therapeutics Inc.
  113. F. Hoffman-La Roche Ltd Diagnostics Division
  114. FlexSite Diagnostics, Inc.
  115. Focus Diagnostics (unit of Quest Diagnostics)
  116. GDS Technology (unit of Stanbio)
  117. GE Medical Systems
  118. GenePOC, Inc.
  119. GeneWeave Biosciences
  120. Gen-Probe
  121. GenturaDx
  122. GlaxoSmithKline
  123. GlucoLight
  124. Glucostats System Ptd Ltd.
  125. Genentech Inc. (Roche)
  126. Genomic Health, Inc.
  127. Grifols
  128. HandyLab
  129. Hanh & Hanh
  130. Helena Laboratories, Inc.
  131. HemoCue AB
  132. Henry Schein
  133. Hemosense (Inverness)
  134. Hologic
  135. Home Diagnostics
  136. HomeDrugTestingKit.com
  137. Home Health Testing
  138. Horiba Ltd.
  139. Humasis
  140. Hycor Biomedical (unit of Agilent Technologies)
  141. Ikerlan
  142. Immunodiagnostic Systems Inc.
  143. Illumina, Inc.
  144. Immucor Inc.
  145. Infectio Diagnostic (unit of BD/Geneohm)
  146. InLight Solutions
  147. Innogenetics Solvay Pharmaceuticals
  148. Instant Technologies
  149. Instrumentation Laboratory
  150. Integrity Applications
  151. IRIS International
  152. International Technidyne (Thoratec)
  153. Invacare
  154. Inverness Medical Innovations
  155. Invitrogen
  156. Iquum
  157. Ionian Technologies Inc.
  158. ISIS Pharmaceuticals
  159. Itamar Medical
  160. ITC Nexus Holding Company (ITC)
  161. ITI -Scottish Enterprise
  162. Johnson & Johnson
  163. The Kroger Co
  164. LabNOW
  165. Lattice
  166. Leica Microsystems GmbH
  167. Lein Applied Diagnostics
  168. LifeScan/Johnson&Johnson
  169. LighTouch Medical
  170. LifeSign LLC
  171. Life Technologies Corporation
  172. LRE Relais + Elektronik
  173. Luminex Corporation
  174. Magellan Biosciences
  175. mBio Diagnostics (division of Precision Photonics)
  176. McKesson
  177. MDY Healthcare Plc (formerly Medisys)
  178. Medarex
  179. Med BioGene LungExpress Dx
  180. Medica
  181. Medicine Devices/AL Systeme
  182. Medimmune
  183. Medonic (unit of Boule Diagnostics/Boule Medical AB)
  184. Medtox Scientific Inc.
  185. Medtronic Inc.
  186. Meridian Bioscience
  187. Mesa International
  188. MicroIslet
  189. Micronics
  190. Mindray Medical International
  191. Mitsubishi Chemical
  192. MolecularMD
  193. Multum
  194. Myriad Genetics Inc.
  195. Nanosphere Inc.
  196. NanoString
  197. Nephromics, LLC
  198. Nihon Kohden
  199. Nikon Instruments Inc.
  200. NinePoint Medical
  201. Nipro Medical Corporation
  202. Northrop Grumman
  203. Nova Biomedical
  204. Novartis Vaccines & Diagnostics, Inc.
  205. Olympus diagnostics (see Beckman Coulter)
  206. Opti Medical
  207. OraSure Technologies Inc.
  208. Organon Teknika (bioMerieux)
  209. Orgenics
  210. OrSense
  211. Ortho Clinical Diagnostics
  212. Pfizer
  213. Phadia
  214. Phamatech
  215. Phylos Inc.
  216. Polymedco
  217. Polymer Technology Systems
  218. PrimeraDx
  219. Procter & Gamble
  220. Prodesse
  221. PSS World Medical
  222. PVT Probenverteiltechnik GmbH
  223. Pyrosequencing AB (see Qiagen)
  224. QBC Diagnostics/The Drucker Company
  225. Qiagen
  226. QuantaLife
  227. Quantimetrix Corporation
  228. Quest Diagnostics
  229. Quidel, Inc.
  230. Quotient Diagnostics Ltd.
  231. Russell House
  232. Radiometer International A/S
  233. Randox laboratories
  234. Response Biomedical
  235. Rite-Aid
  236. Roche Diagnostics
  237. Samsung Electronics Co., Ltd.
  238. Sequenom
  239. SDI Biomed Inc.
  240. Seegene
  241. Shimadzu Corporation
  242. Siemens Healthcare Diagnostics
  243. SomaLogic, Inc.
  244. Spartan Biosciences
  245. Spectral Diagnostics, Inc.
  246. Stanbio Laboratory
  247. SuperArray Bioscience (Qiagen)
  248. Syndax Pharmaceuticals, Inc.
  249. Syntron
  250. Sysmex
  251. Target
  252. Techno Medica Co. Ltd.
  253. Technoclone GmbH
  254. Therasense/Abbott Diabetes Care Inc.
  255. Thermo Fisher Scientific Inc.
  256. Third Wave Technologies
  257. Thoratec
  258. Tony Diagnostics Ltd.
  259. Tokyo Boeki Pty Ltd
  260. Tosoh
  261. Trek Diagnostic Systems
  262. TriPath Imaging (unit of BD)
  263. Trinity Biotech
  264. University of Zaragoza
  265. Vantix Ltd
  266. Ventana Medical Systems, Inc.
  267. Veralight
  268. Vermillion
  269. Veridex LLC (J&J)
  270. Verum Diagnostica GmbH
  271. Visual Pathways
  272. Vital Diagnostics
  273. VitaLab
  274. Vision Biosystems (Leica Microsystems)
  275. VivoMedical
  276. Walgreen Company
  277. Walmart Stores
  278. Wampole Laboratories
  279. Wescor Biomedical Systems
  280. XDx -Expression Diagnostics
  281. Yellow Springs Instruments, Inc.
  282. Yeongdong Pharmaceutical Corp
  283. Yu.Sys
  284. Zyomyx, Inc.
Contact Us

Need help finding medtech research? Let us help you!